PERSPECTIVE article
Front. Toxicol.
Sec. Occupational Toxicology
Volume 7 - 2025 | doi: 10.3389/ftox.2025.1625874
Uncovering exposome-related diseases through the pathologic metallome: a novel approach for clinical populations
Provisionally accepted- Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Environmental exposure to complex metal mixtures plays a critical role in the onset and progression of diverse chronic diseases, in ways that traditional toxicological framework fails to capture. A paradigm shift is underway, moving toward a more integrated understanding of combined metal effects through the interdisciplinary study of the metallome, the distribution of metal ions and metalloids within a biological system. In this perspective, we highlight the clinical importance of metallome to identify specific subpopulations in which disease onset or progression is primarily driven by environmental metal exposure rather than genetic predisposition. To achieve this goal, robust and sensitive analytical methods are required to overcome the limitations of conventional approaches and enable the detection of the full spectrum of metal species, including metals sequestered within mineral particles present in body fluids and tissues. We propose methodological innovations in sample preparation and analysis that expand the current scope of metallome-associated research. Together, these advances support a comprehensive framework for assessing metal mixture effects in environmental health, bridging toxicology with clinical practice and enabling more targeted, exposure-informed public health interventions.
Keywords: Metal toxicology, Metallome, metallomics, Metal exposure, Exposome, chronic diseases, Patients, clinical applications
Received: 09 May 2025; Accepted: 18 Jul 2025.
Copyright: © 2025 Leinardi and Huaux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Riccardo Leinardi, Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.